Reactions Weekly

, Volume 1761, Issue 1, pp 2–2 | Cite as

Febuxostat: higher risk of CV-related death, all-cause mortality

News item


  1. Gillian A. Febuxostat: increased risk of cardiovascular death and all-cause mortality in patients treated with febuxostat in the CARES study. Internet Document : [3 pages], 27 Jun 2019. Available from: URL:

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations